SURITAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Surital, and what generic alternatives are available?
Surital is a drug marketed by Parkedale and is included in one NDA.
The generic ingredient in SURITAL is thiamylal sodium. There are three drug master file entries for this compound. Additional details are available on the thiamylal sodium profile page.
Summary for SURITAL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 19 |
Patent Applications: | 1,041 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SURITAL at DailyMed |
US Patents and Regulatory Information for SURITAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parkedale | SURITAL | thiamylal sodium | INJECTABLE;INJECTION | 007600-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Parkedale | SURITAL | thiamylal sodium | INJECTABLE;INJECTION | 007600-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Parkedale | SURITAL | thiamylal sodium | INJECTABLE;INJECTION | 007600-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |